These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1102 related items for PubMed ID: 29253680

  • 1. Effect of lacosamide on depression and anxiety symptoms in patients with focal refractory epilepsy: A prospective multicenter study.
    Rocamora R, Ley M, Molins A, Toledo M, Sansa G, Bertol V, Becerra JL, Carreño M, Mauri JÁ.
    Epilepsy Behav; 2018 Feb; 79():87-92. PubMed ID: 29253680
    [Abstract] [Full Text] [Related]

  • 2. The effects of lacosamide on cognition, quality-of-life measures, and quality of life in patients with refractory partial epilepsy.
    Lancman ME, Fertig EJ, Trobliger RW, Perrine K, Myers L, Iyengar SS, Malik M.
    Epilepsy Behav; 2016 Aug; 61():27-33. PubMed ID: 27315132
    [Abstract] [Full Text] [Related]

  • 3. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
    Maschio M, Zarabla A, Maialetti A, Fabi A, Vidiri A, Villani V, Giannarelli D.
    Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
    [Abstract] [Full Text] [Related]

  • 4. LAM study: Effects of lacosamide on behaviour and quality of life in patients with epilepsy.
    Alfaro A, Asensio M, García-Escrivá A, Medrano V, Salom JM, Tortosa D, Palao S, Lezcano M, Berenguer L, Navarro M, Cerdán M, Buendía JF, Giner JC.
    Neurologia (Engl Ed); 2019 Aug; 34(1):1-6. PubMed ID: 27993420
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and tolerability of adjuvant lacosamide: The role of clinical characteristics and mechanisms of action of concomitant AEDs.
    Neal A, D'Souza W, Hepworth G, Lawn N, Cook M, Nikpour A.
    Epilepsy Behav; 2018 Mar; 80():25-32. PubMed ID: 29396359
    [Abstract] [Full Text] [Related]

  • 6. Improved irritability, mood, and quality of life following introduction of perampanel as late adjunctive treatment for epilepsy.
    Moraes JS, Hepworth G, Ignatiadis S, Dharan A, Carne R, Seneviratne U, Cook MJ, D'Souza WJ.
    Epilepsy Behav; 2020 Mar; 104(Pt A):106883. PubMed ID: 32045874
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. LACONORTE study: Efficacy and security of lacosamide as first add-on therapy for focal-onset epilepsy in real-life setting.
    Muñoz-Lopetegi A, López-González FJ, Rodríguez-Osorio X, Pato Pato A, Bellas Lamas P, Abella-Corral J, Castro Vilanova MD, Garea MJ, Gil López JA, Ruiz-Martínez J, Poza JJ.
    Epilepsy Res; 2018 Sep; 145():51-54. PubMed ID: 29890341
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Long-term efficacy of add-on lacosamide treatment in children and adolescents with refractory epilepsies: A single-center observational study.
    Rosati A, Ilvento L, Rizzi R, Doccini V, Leo MC, Pugi A, De Masi S, Guerrini R.
    Epilepsia; 2018 May; 59(5):1004-1010. PubMed ID: 29663335
    [Abstract] [Full Text] [Related]

  • 13. The effects of lacosamide on depression and anxiety in patients with epilepsy.
    Moseley BD, Cole D, Iwuora O, Strawn JR, Privitera M.
    Epilepsy Res; 2015 Feb; 110():115-8. PubMed ID: 25616463
    [Abstract] [Full Text] [Related]

  • 14. Determinants of quality of life in patients with refractory focal epilepsy who were not eligible for surgery or who rejected surgery.
    Elsharkawy AE, Thorbecke R, Ebner A, May TW.
    Epilepsy Behav; 2012 Jun; 24(2):249-55. PubMed ID: 22534356
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effectiveness and tolerability of lacosamide as add-on therapy in patients with brain tumor-related epilepsy: Results from a prospective, noninterventional study in European clinical practice (VIBES).
    Rudà R, Houillier C, Maschio M, Reijneveld JC, Hellot S, De Backer M, Chan J, Joeres L, Leunikava I, Glas M, Grant R.
    Epilepsia; 2020 Apr; 61(4):647-656. PubMed ID: 32329527
    [Abstract] [Full Text] [Related]

  • 19. Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study.
    Del Bianco C, Placidi F, Liguori C, Mari L, Ulivi M, Ornello R, Pisani A, Mercuri NB, Izzi F.
    Epilepsy Behav; 2019 May; 94():178-182. PubMed ID: 30959275
    [Abstract] [Full Text] [Related]

  • 20. Effects of adjunctive lacosamide on mood and quality of life in patients with epilepsy.
    Nakhutina L, Kunnakkat SD, Coleman M, Lushbough C, Arnedo V, Soni N, Grant AC.
    Epilepsy Behav; 2017 Aug; 73():90-94. PubMed ID: 28623755
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.